Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD).
Janet Rea HardyRistan M GreerGeorgie HuggettAlison KearneyTaylan GurgenciPhillip GoodPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
CBD oil did not add value to the reduction in symptom distress provided by specialist palliative care alone.